NasdaqCM - Delayed Quote USD
FibroBiologics, Inc. (FBLG)
0.8315
-0.0085
(-1.01%)
At close: May 14 at 4:00:01 PM EDT
0.8099
-0.02
(-2.60%)
Pre-Market: 9:04:18 AM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-11,901
-11,901
-6,401
-4,066
-1,410
Investing Cash Flow
-184
-184
-495
0
--
Financing Cash Flow
16,907
16,907
13,793
5,925
1,817
End Cash Position
13,985
13,985
9,163
2,266
407
Income Tax Paid Supplemental Data
0
0
0
0
0
Interest Paid Supplemental Data
20
20
2
0
0
Capital Expenditure
-184
-184
-495
--
--
Issuance of Capital Stock
7,507
7,507
16,138
2,150
0
Issuance of Debt
9,400
9,400
300
4,300
2,275
Repayment of Debt
--
--
0
-525
-750
Free Cash Flow
-12,085
-12,085
-6,896
-4,066
-1,410
12/31/2021 - 2/1/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ACRV Acrivon Therapeutics, Inc.
1.1400
+0.88%
OKUR OnKure Therapeutics, Inc.
1.8300
-0.54%
RLYB Rallybio Corporation
0.3095
+3.86%
OKYO OKYO Pharma Limited
1.3400
-6.29%
ALLK Allakos Inc.
0.3291
-0.06%
IPSC Century Therapeutics, Inc.
0.4891
-7.02%
KYTX Kyverna Therapeutics, Inc.
2.1500
-7.33%
APLT Applied Therapeutics, Inc.
0.4852
+10.25%
RNXT RenovoRx, Inc.
1.0500
+1.94%
LCTX Lineage Cell Therapeutics, Inc.
0.4580
-2.55%